Company News: Express Scripts, Medco, Roche, Eli Lilly

Share this article:
Pharmacy benefit manager (PBM) Express Scripts said it plans to buy rival Medco Health Solutions, currently the largest PBM, for $29.1 billion. A combined company could have more pull in negotiating drug prices. The planned merger comes shortly after Medco lost its biggest contract, an $11 billion account with UnitedHealth Group which had accounted for 17% of Medco's business.

Roche said sales were down 4% and 2% for the second quarter and first six months, respectively. Accounting for some of this decline were decreases in sales of cancer drug Avastin (down 7%) and leukemia med Rituxan (down 3%). Diagnostics sales were also down about 2%.

Eli Lilly reported second-quarter revenue up 9% to $6.3 billion, beating analyst consensus by 4%. Lilly did not include any significant pipeline updates in the Q2 report.


Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

FDA lifts OncoMed partial hold

The FDA froze the clinical trial of anti-Fzd7 vantictumab in July over concern about "bone-related adverse events."

Research links estrogen and binge eating

Baylor College of Medicine researchers have found that an estrogen replacement suppressed binge-eating behavior among lab mice.

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.